- Archemix Corp.
Company developing therapeutics of aptamers, for the prevention and treatment of chronic and acute disease. Includes overview of technology and commercial potential, careers and contacts in Cambridge, Massachusetts.
http://www.archemix.com/
(Added: Mon Apr 04 2011 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It
- AVI Biopharma, Inc.
Develops and commercializes a vaccine against human chorionic gonadotropin secreting cancers, and synthetic antisense technology to inhibit translation in treating cardiovascular, kidney and viral diseases. Research and manufacturing facilities in Corvallis, Oregon. (Nasdaq: AVII)
http://www.antivirals.com/
(Added: Mon Apr 04 2011 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It
- Avigen, Inc.
Develops gene-based therapeutic products derived from adeno-associated virus for the treatment of inherited and acquired diseases. Includes explanation of technology, product pipeline, collaborative partnerships and investment data, from manufacturing facility in Alameda, California. (Nasdaq: AVGN)
http://www.avigen.com/
(Added: Mon Apr 04 2011 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It
- Curis, Inc
Developing small molecule and peptide drugs in regulatory signaling and regenerative pathways. Introduces technical background, product pipeline, collaborations, investment data and careers headquartered from Cambridge, Massachusetts. (Nasdaq: CVGP)
http://www.curis.com/
(Added: Mon Apr 04 2011 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It
- Cyano Biotech GmbH.
Identifies and characterises structural variants of polyketides and non-ribosomal cyclic heptapeptides from cyanobacteria, and optimises pharmacological activity using biocombinatorial techniques. Profile, collaborators and contacts in Germany.
http://www.cyano-biotech.com/
(Added: Mon Apr 04 2011 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It
- EntreMed, Inc.
Researches and develops biopharmaceutical products which address the role of blood and blood vessels in the prevention and treatment of diseases by inhibiting growth or enhancing bioavailability of drugs. Based in Rockville, Maryland. (Nasdaq: ENMD)
http://www.entremed.com/
(Added: Mon Apr 04 2011 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It
- Gemac
Researching diagnostics and drug candidates for the treatment of amyotrophic lateral and multiple sclerosis, as well as autoimmune diseases, including anti-idiotypic antibodies. Includes overview of corporation in Cenon, France.
http://www.gemacbio.com/
(Added: Mon Apr 04 2011 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It
- Genentech, Inc.
Development, production, and marketing of human therapeutics. Includes research history, product pipeline, global corporate and career information. San Francisco, California.
http://www.gene.com/
(Added: Mon Apr 04 2011 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It
- Genfit
Researching nuclear receptors and gene deregulation for treatment of cardiovascular, metabolic and inflammatory diseases. Includes information about genomic research headquartered in Loos, France.
http://www.genfit.com/
(Added: Mon Apr 04 2011 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It
- m-phasys GmbH
Focused on the discovery of therapeutics for GPCRs and other membrane proteins. Information on research activities, services, management, press releases and directions. Located in Tübingen, Germany.
http://www.m-phasys.com/
(Added: Mon Apr 04 2011 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It
- MannKind Corp.
Developing a pulmonary insulin delivery system, and immunotherapy of cancer, by identifying tumor-related antigens, DNA and peptide-based drugs evoking cell-mediated responses. Located in Valencia, California.
http://www.mannkindcorp.com/
(Added: Mon Apr 04 2011 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It
- Maxygen, Inc.
Develops proprietary protein modifications including PEG, glycosylation and vaccines. Overview of technologies, clinical trial pipeline, investor data and careers in Redwood City, California. (Nasdaq: MAXY)
http://www.maxygen.com/
(Added: Mon Apr 04 2011 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It
- Mixture Sciences, Inc.
A privately held company that specializes in research for treatment of cancer, diabetes, multiple sclerosis, HIV/AIDS and infectious diseases, including Lyme Disease. Lists research projects and procedures. Based in San Diego, California.
http://www.mixturesciences.com/
(Added: Mon Apr 04 2011 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It
- Neurocrine Biosciences, Inc.
Discovers and develops therapeutics for treatment of diseases and disorders of the central nervous and immune systems, including anxiety, depression, alzheimer's disease, obesity, stroke and multiple sclerosis. (Nasdaq: NBIX).
http://www.neurocrine.com/
(Added: Mon Apr 04 2011 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It
- Novacta Biosystems Ltd.
Drug discovery and development company using pathway engineering and chemistry to optimise the activity of natural products for the treatment of infectious diseases. Introduces biotransformation technology, lead compounds, key personnel in Hatfield, England.
http://www.novactabio.com/
(Added: Mon Apr 04 2011 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It
- Nymox Pharmaceutical Corp.
Researches and develops neurological diagnostics and pharmaceuticals for the aging population with emphasis on Alzheimer's disease. Profile of company with bases in Maywood, New Jersey and Saint Laurent, Quebec. (Nasdaq: NYMX)
http://www.nymox.com/
(Added: Mon Apr 04 2011 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It
- Rib-X Pharmaceuticals Inc.
Structure-based drug design start-up, specializing in the ribosome as a target, and bacterial antibiotic resistance. Includes mechanisms of action, glossary, careers, corporate news and contacts and directions in New Haven, Connecticut.
http://www.rib-x.com/
(Added: Mon Apr 04 2011 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It
- SIGA Technologies Inc.
Develops and commercializes vaccines, and novel antiviral therapeutics for category A pathogens, infectious diseases, and potential bio-defense. Laboratories in Corvallis, Oregon, headquartered in New York City. (Nasdaq: SIGA)
http://www.siga.com/
(Added: Mon Apr 04 2011 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It
- Trimeris, Inc.
Discovers and develops novel therapeutic agents which block viral infection by inhibiting viral fusion with host cells, as in anti-HIV therapy. Includes overview of projects, investment data, and profile of company in Durham, North Carolina. (Nasdaq: TRMS)
http://www.trimeris.com/
(Added: Mon Apr 04 2011 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It
- Xencor, Inc.
Technology for MHC epitope removal, glycosylation to optimize pharmacokinetics, masking immune recognition sites and engineering monoclonal antibodies. Includes discovery programs, partnering opportunities in Monrovia, California. ImmunoPDAâ„¢ Technology Product Sheet Caltech spin-off developing proteomic technologies to accelerate drug discovery.
http://www.xencor.com/
(Added: Mon Apr 04 2011 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It
- Xoma
Development and manufacture of recombinant proteins and peptides, in partnership with big pharmas. Includes licensing of technology derived from the host-defense protein BPI, monoclonal antibodies to treat chemotherapy-induced thrombocytopenia, and to target cancer. Based in Berkeley, California.
http://www.xoma.com/
(Added: Mon Apr 04 2011 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It
- ZymoGenetics, Inc.
Discovery, development and commercialization of therapeutic proteins for the prevention and treatment of human diseases. Includes product pipeline, news on clinical trials and profile of company in Seattle, Washington.
http://www.zymogenetics.com/
(Added: Mon Apr 04 2011 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It
|
